close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Blueprint Medicines Corporation - Common Stock (NQ:BPMC)

129.46 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Blueprint Medicines Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
BPMC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Blueprint Medicines Corporation Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
US Stocks Likely To Open Lower After A Solid May: 'TACO' Trade And 'Run It Hot' Optimism 'Are Consensus At This Point,' Says Expert ↗
U.S. stock futures fell on Monday after a mixed close on Friday. Futures of major benchmark indices were trading lower in premarket. 
Via Benzinga
News headline image
Campbell's, SAIC And 3 Stocks To Watch Heading Into Monday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 1, 2025 ↗
 
Via Benzinga
News headline image
Blueprint Medicines Earnings Preview ↗
 
Via Benzinga
News headline image
13 Analysts Assess Blueprint Medicines: What You Need To Know ↗
 
Via Benzinga
News headline image
Breaking Down Blueprint Medicines: 10 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
Analyst Expectations For Blueprint Medicines's Future ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Blueprint Medicines Stock ↗
 
Via Benzinga
News headline image
Breaking Down Blueprint Medicines: 14 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts ↗
 
Via Benzinga
News headline image
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
IonQ, H&E Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗
Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush... 
Via Benzinga
News headline image
What Analysts Are Saying About Blueprint Medicines Stock ↗
 
Via Benzinga
News headline image
Is NASDAQ:BPMC a Fit for high Growth Investing Strategies? ↗
Why the high growth investor may take a look at BLUEPRINT MEDICINES CORP (NASDAQ:BPMC). 
Via Chartmill
News headline image
Key Takeaways From Blueprint Medicines Analyst Ratings ↗
 
Via Benzinga
News headline image
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst ↗
JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit's significant growth, 2024 revenue forecast, and potential strategic opportunities. 
Via Benzinga
News headline image
Analyst Ratings For Blueprint Medicines ↗
 
Via Benzinga
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
15 Analysts Have This To Say About Blueprint Medicines ↗
 
Via Benzinga
News headline image
Expert Ratings For Blueprint Medicines ↗
 
Via Benzinga
News headline image
Assessing Blueprint Medicines: Insights From 16 Financial Analysts ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Blueprint Medicines Corporation and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Unveiling 18 Analyst Insights On Blueprint Medicines ↗
 
Via Benzinga
News headline image
BPMC Stock Earnings: Blueprint Medicines Beats EPS, Beats Revenue for Q1 2024 ↗
BPMC stock results show that Blueprint Medicines beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today